Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 6 (2009), Issue 7 (July)

1. Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.
   Br J Cancer, 101(1): 124-31. [Abstract] [Full-text]
2. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.
   Cancer Cell, 16(1): 9-20. [Abstract] [Full-text]
3. Real-time quantitative polymerase chain reaction (qPCR) analysis with fluorescence resonance energy transfer (FRET) probes reveals differential expression of the four ERBB4 juxtamembrane region variants between medulloblastoma and pilocytic astrocytoma.
   Neuropathol Appl Neurobiol, 35(4): 353-66. [Abstract] [Full-text]
4. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
   Int J Cancer, 125(3): 530-40. [Abstract] [Full-text]
5. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells.
   Int J Cancer, 125(3): 717-22. [Abstract] [Full-text]
6. IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era.
   Int J Cancer, 125(3): 680-7. [Abstract] [Full-text]
7. Reduction of Akt2 inhibits migration and invasion of glioma cells.
   Int J Cancer, 125(3): 585-95. [Abstract] [Full-text]
8. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
   J Neurooncol, 94(1): 1-19. [Abstract] [Full-text]
9. Local controlled delivery of anti-neoplastic RNAse to the brain.
   Pharm Res, 26(8): 1838-46. [Abstract] [Full-text]
10. Reanalysis of neuroblastoma expression profiling data using improved methodology and extended follow-up increases validity of outcome prediction.
    Cancer Lett, 282(1): 55-62. [Abstract] [Full-text]
11. Cerebral glioblastoma with oligodendrogliomal component: analysis of 36 cases.
    J Neurooncol, 94(1): 129-34. [Abstract] [Full-text]
12. Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET).
    Crit Rev Oncol Hematol, 71(2): 165-79. [Abstract] [Full-text]
13. In vivo proton magnetic resonance spectroscopy of intraventricular tumours of the brain.
    Eur Radiol, 19(8): 2049-59. [Abstract] [Full-text]
14. Factors influencing activities of daily living using FIM-FAM scoring system before starting adjuvant treatment in patients with brain tumors: results from a prospective study.
    J Neurooncol, 94(1): 103-10. [Abstract] [Full-text]
15. Correlation of alternative splicing of the D2 dopamine receptor mRNA and estrogen receptor mRNA in the prolactinomas and gonadotrope tumors.
    J Neurooncol, 94(1): 135-9. [Abstract] [Full-text]
16. Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin.
    J Neurooncol, 94(1): 41-50. [Abstract] [Full-text]
17. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.
    J Neurooncol, 94(1): 87-96. [Abstract] [Full-text]
18. Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression.
    J Neurooncol, 94(1): 97-101. [Abstract] [Full-text]
19. Multifarious proteomic signatures and regional heterogeneity in glioblastomas.
    J Neurooncol, 94(1): 31-9. [Abstract] [Full-text]
20. Dapsone induced methemoglobinemia in a patient with glioblastoma.
    J Neurooncol, 94(1): 149-52. [Abstract] [Full-text]
21. Glioblastoma in multiple sclerosis: a case report.
    J Neurooncol, 94(1): 141-4. [Abstract] [Full-text]
22. Cisplatinum and BCNU chemotherapy in primary glioblastoma patients.
    J Neurooncol, 94(1): 57-62. [Abstract] [Full-text]
23. Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing.
    J Neurooncol, 94(1): 79-85. [Abstract] [Full-text]
24. Tonsillary carcinoma after temozolomide treatment for glioblastoma multiforme: treatment-related or dual-pathology?
    J Neurooncol, 94(1): 145-8. [Abstract] [Full-text]
25. Quality of radiosurgery for single brain metastases with respect to treatment technology: a matched-pair analysis.
    J Neurooncol, 94(1): 69-77. [Abstract] [Full-text]
26. Expression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargeting.
    J Neurooncol, 94(1): 21-30. [Abstract] [Full-text]
27. Differential response of glioma cells to FOXO1-directed therapy.
    Cancer Res, 69(13): 5433-40. [Abstract] [Full-text]
28. Development of a positron probe for localization and excision of brain tumours during surgery.
    Phys Med Biol, 54(14): 4439-53. [Abstract] [Full-text]
29. Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype.
    Neuropathol Appl Neurobiol, 35(4): 380-93. [Abstract] [Full-text]
30. Vesicle amine transport protein-1 (VAT-1) is upregulated in glioblastomas and promotes migration.
    Neuropathol Appl Neurobiol, 35(4): 342-52. [Abstract] [Full-text]
31. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.
    Glia, 57(11): 1143-53. [Abstract] [Full-text]
32. Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors.
    J Clin Endocrinol Metab, 94(7): 2634-43. [Abstract] [Full-text]
33. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
    Nucl Med Commun, 30(8): 602-9. [Abstract] [Full-text]
34. Molecular mechanisms of HIF-1alpha modulation induced by oxygen tension and BMP2 in glioblastoma derived cells.
    PLoS One, 4(7): e6206. [Abstract] [Full-text]
35. Meningitis as a presentation of macroprolactinoma.
    Exp Clin Endocrinol Diabetes, 117(7): 361-4. [Abstract] [Full-text]
36. Brain metastasis of a papillary renal cell carcinoma, identified as type 2.
    Int J Clin Oncol, 14(3): 270-2. [Abstract] [Full-text]
37. The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.
    Expert Opin Biol Ther, 9(8): 1087-98. [Abstract] [Full-text]
38. Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells.
    Toxicol Sci, 110(2): 376-88. [Abstract] [Full-text]
39. Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.
    Eur J Nucl Med Mol Imaging, 36(8): 1265-72. [Abstract] [Full-text]
40. Characterization of brain cancer stem cells: a mathematical approach.
    Cell Prolif, 42(4): 529-40. [Abstract] [Full-text]
41. Virtual glioblastoma: growth, migration and treatment in a three-dimensional mathematical model.
    Cell Prolif, 42(4): 511-28. [Abstract] [Full-text]
42. Non-surgical management of hormone-secreting pituitary tumors.
    J Clin Neurosci, 16(8): 985-93. [Abstract] [Full-text]
43. Intracerebral cystic rhabdoid meningioma.
    J Clin Neurosci, 16(8): 1073-4. [Abstract] [Full-text]
44. Pediatric multicentric glioma occurring after cranial irradiation.
    J Clin Neurosci, 16(8): 1086-8. [Abstract] [Full-text]
45. Isolation of tumour stem-like cells from benign tumours.
    Br J Cancer, 101(2): 303-11. [Abstract] [Full-text]
46. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
    JAMA, 302(3): 276-89. [Abstract] [Full-text]
47. A network model of a cooperative genetic landscape in brain tumors.
    JAMA, 302(3): 261-75. [Abstract] [Full-text]
48. Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours.
    Clin Endocrinol (Oxf), 71(2): 226-33. [Abstract] [Full-text]
49. BMI1 sustains human glioblastoma multiforme stem cell renewal.
    J Neurosci, 29(28): 8884-96. [Abstract] [Full-text]
50. Kinome profiling in pediatric brain tumors as a new approach for target discovery.
    Cancer Res, 69(14): 5987-95. [Abstract] [Full-text]
51. A comparison between sevoflurane and desflurane anesthesia in patients undergoing craniotomy for supratentorial intracranial surgery.
    Anesth Analg, 109(2): 567-71. [Abstract] [Full-text]
52. A brainstem paraneoplastic syndrome associated with prostate cancer.
    J Neurol Neurosurg Psychiatry, 80(8): 934-5. [Abstract] [Full-text]
53. A systems biology-based gene expression classifier of glioblastoma predicts survival with solid tumors.
    PLoS One, 4(7): e6274. [Abstract] [Full-text]
54. Brain-skull contact boundary conditions in an inverse computational deformation model.
    Med Image Anal, 13(4): 659-72. [Abstract] [Full-text]
55. Cognitive deficits and predictors 3 years after diagnosis of a pilocytic astrocytoma in childhood.
    J Clin Oncol, 27(21): 3526-32. [Abstract] [Full-text]
56. The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP.
    Neurochem Int, 55(6): 423-30. [Abstract] [Full-text]
57. Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-beta.
    Cancer Gene Ther, 16(8): 664-71. [Abstract] [Full-text]
58. Pituitary adenoma with craniopharyngioma component.
    Hum Pathol, 40(8): 1189-93. [Abstract] [Full-text]
59. Intracranial ependymomas in children: society of pediatric oncology experience with postoperative hyperfractionated local radiotherapy.
    Int J Radiat Oncol Biol Phys, 74(5): 1536-42. [Abstract] [Full-text]
60. Phase I study of concurrent whole brain radiotherapy and erlotinib for multiple brain metastases from non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 74(5): 1391-6. [Abstract] [Full-text]
61. Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors.
    Int J Radiat Oncol Biol Phys, 74(5): 1543-8. [Abstract] [Full-text]
62. Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy.
    PLoS One, 4(7): e6314. [Abstract] [Full-text]
63. Thallium-201 SPECT in brain gliomas: Quantitative assessment in differential diagnosis between tumor recurrence and radionecrosis.
    Clin Nucl Med, 34(8): 503-5. [Abstract] [Full-text]
64. Yolk sac tumor in the fourth ventricle: a case report.
    Clin Neurol Neurosurg, 111(7): 636-7. [Abstract] [Full-text]
65. Outcome of teenagers and young adults with ependymoma: the Royal Marsden experience.
    Childs Nerv Syst, 25(9): 1047-52. [Abstract] [Full-text]
66. Metastatic craniopharyngioma: case report and literature review.
    Childs Nerv Syst, 25(9): 1143-7. [Abstract] [Full-text]
67. Loss of fine motor function correlates with ataxia and decline of cognition in cerebellar tumor survivors.
    Pediatr Blood Cancer, 53(3): 424-31. [Abstract] [Full-text]
68. High-grade dural arteriovenous fistula simulating a bilateral thalamic neoplasm.
    Clin Neurol Neurosurg, 111(7): 629-32. [Abstract] [Full-text]
69. Diffuse craniospinal metastases of intraventricular rhabdoid papillary meningioma with glial fibrillary acidic protein expression: a case report.
    Clin Neurol Neurosurg, 111(7): 619-23. [Abstract] [Full-text]
70. Endoscopic biopsy of foramen of Monro and third ventricle lesions guided by frameless neuronavigation: usefulness and limitations.
    Clin Neurol Neurosurg, 111(7): 579-82. [Abstract] [Full-text]
71. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells.
    Oncogene, 28(28): 2593-605. [Abstract] [Full-text]
72. Predictors of access to pituitary tumor resection in the United States, 1988-2005.
    Eur J Endocrinol, 161(2): 259-65. [Abstract] [Full-text]
73. Radiation-induced gliomas following radiotherapy for craniopharyngiomas: a case report and review of the literature.
    Clin Neurol Neurosurg, 111(7): 591-6. [Abstract] [Full-text]
74. Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma.
    Pediatr Blood Cancer, 53(3): 496-8. [Abstract] [Full-text]
75. Small molecule inhibitors in children with malignant gliomas.
    Pediatr Blood Cancer, 53(3): 312-7. [Abstract] [Full-text]
76. A prospective, blinded analysis of A-PROTEIN (recoverin or CAR protein) levels in pediatric patients with central nervous system tumors.
    Pediatr Blood Cancer, 53(3): 343-7. [Abstract] [Full-text]
77. Anaplastic astroblastoma of childhood: aggressive behavior.
    Childs Nerv Syst, 25(9): 1125-9. [Abstract] [Full-text]
78. Recurrence of intracranial tumors following adoptive T cell therapy can be prevented by direct and indirect killing aided by high levels of tumor antigen cross-presented on stromal cells.
    J Immunol, 183(3): 1828-37. [Abstract] [Full-text]
79. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC.
    Int J Cancer, 125(6): 1407-13. [Abstract] [Full-text]
80. Tumor microvasculature supports proliferation and expansion of glioma-propagating cells.
    Int J Cancer, 125(5): 1222-30. [Abstract] [Full-text]
81. Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness.
    Int J Cancer, 125(5): 1054-64. [Abstract] [Full-text]
82. A neurosurgeon's guide to stem cells, cancer stem cells, and brain tumor stem cells.
    Neurosurgery, 65(2): 237-49; discussion 249-50; quiz N6. [Abstract] [Full-text]
83. Primary suprasellar malignant tumor with odontogenic features: case report.
    Neurosurgery, 65(2): E380-2; discussion E382. [Abstract] [Full-text]
84. Endogenous tenascin-C enhances glioblastoma invasion with reactive change of surrounding brain tissue.
    Cancer Sci, 100(8): 1451-9. [Abstract] [Full-text]
85. Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.
    J Psychopharmacol, 23(6): 723-6. [Abstract] [Full-text]
86. Intracerebral schwannoma in a child with infiltration along perivascular spaces resembling meningioangiomatosis.
    Pathol Int, 59(8): 583-7. [Abstract] [Full-text]
87. A novel role of HLA class I in the pathology of medulloblastoma.
    J Transl Med, 7: 59. [Abstract] [Full-text]
88. Familial pituitary tumor syndromes.
    Nat Rev Endocrinol, 5(8): 453-61. [Abstract] [Full-text]
89. Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients.
    Acta Neurochir (Wien), 151(8): 947-60. [Abstract] [Full-text]
90. Isolated contralateral post-ictal oculomotor nerve palsy following supratentorial craniotomy. Case report.
    Acta Neurochir (Wien), 151(8): 999-1000; discussion 1000. [Abstract] [Full-text]
91. Medial wall of the cavernous sinus: microanatomical diaphanoscopic and episcopic investigation.
    Acta Neurochir (Wien), 151(8): 961-7; discussion 967. [Abstract] [Full-text]
92. Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model.
    Cancer Immunol Immunother, 58(10): 1627-34. [Abstract] [Full-text]
93. Pregnancy outcome in pituitary tumors.
    Arch Gynecol Obstet, 280(3): 401-4. [Abstract] [Full-text]
94. Infiltrating CTLs in human glioblastoma establish immunological synapses with tumorigenic cells.
    Am J Pathol, 175(2): 786-98. [Abstract] [Full-text]
95. Expression of integrin alpha6beta1 enhances tumorigenesis in glioma cells.
    Am J Pathol, 175(2): 844-55. [Abstract] [Full-text]
96. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    J Clin Neurosci, 16(9): 1119-30. [Abstract] [Full-text]
97. Combined modality treatment of newly diagnosed glioblastoma multiforme in a regional neurosurgical centre.
    J Clin Neurosci, 16(9): 1174-9. [Abstract] [Full-text]
98. Microvessel density and vascular endothelial growth factor expression as predictors of childrens' survival from cerebellar medulloblastoma.
    J Clin Neurosci, 16(9): 1199-202. [Abstract] [Full-text]
99. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.
    Cancer, 115(15): 3512-8. [Abstract] [Full-text]
100. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
     Cancer, 115(15): 3501-11. [Abstract] [Full-text]
101. Vanishing glioblastoma after corticosteroid therapy.
     J Clin Neurosci, 16(9): 1226-8. [Abstract] [Full-text]
102. Pituitary apoplexy after joint arthroplasty.
     J Arthroplasty, 24(5): 826.e7-10. [Abstract] [Full-text]
103. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
     Acta Neuropathol, 118(3): 401-5. [Abstract] [Full-text]
104. Expression and functional roles of Smad1 and BMPR-IB in glioma development.
     Cancer Invest, 27(7): 734-40. [Abstract] [Full-text]
105. Pineal region tumors in children: a single center experience.
     Neuropediatrics, 40(1): 15-21. [Abstract] [Full-text]
106. Temozolomide in malignant gliomas: current use and future targets.
     Cancer Chemother Pharmacol, 64(4): 647-55. [Abstract] [Full-text]
107. Quantifying spatial heterogeneity in dynamic contrast-enhanced MRI parameter maps.
     Magn Reson Med, 62(2): 488-99. [Abstract] [Full-text]
108. Flow cytometry analysis of neural differentiation markers expression in human glioblastomas may predict their response to chemotherapy.
     Cell Mol Neurobiol, 29(6): 845-58. [Abstract] [Full-text]
109. Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
     Cancer Chemother Pharmacol, 64(4): 769-75. [Abstract] [Full-text]
110. Multiplanar MRI-CT fusion neuronavigation-guided serial stereotactic biopsy of human brain tumors: proof of a strong correlation between tumor imaging and histopathology by a new technical approach.
     J Cancer Res Clin Oncol, 135(9): 1293-302. [Abstract] [Full-text]
111. Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapy.
     J Cancer Res Clin Oncol, 135(9): 1239-44. [Abstract] [Full-text]
112. Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier.
     Cancer Res, 69(15): 6200-7. [Abstract] [Full-text]
113. Phase II trial of conformal radiation therapy for pediatric low-grade glioma.
     J Clin Oncol, 27(22): 3598-604. [Abstract] [Full-text]
114. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits.
     J Clin Oncol, 27(22): 3691-7. [Abstract] [Full-text]
115. Presurgical (99m)Tc-sestamibi brain SPET/CT versus SPET: a comparison with MRI and histological data in 33 patients with brain tumours.
     Nucl Med Commun, 30(9): 660-8. [Abstract] [Full-text]
116. Quantitative imaging biomarkers in neuro-oncology.
     Nat Rev Clin Oncol, 6(8): 445-54. [Abstract] [Full-text]
117. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.
     J Clin Oncol, 27(22): 3712-22. [Abstract] [Full-text]
118. MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas.
     J Cereb Blood Flow Metab, 29(8): 1373-82. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.